Industry Research Reports

Home > Reports > Pharma & Healthcare > Bictegravir - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Bictegravir - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-11

Pages: 122 Pages

Report ld: 2636005

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Bictegravir is a potent HIV-1 integrase inhibitor primarily used to treat type 1 AIDS without a history of antiretroviral therapy.

(HIV-1) adult patients, it can also be used as an alternative drug for patients with no history of treatment failure and drug resistance and HIV-1 RNA less than 50copies/ml.

The global market for Bictegravir was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Bictegravir was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Bictegravir was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Bictegravir was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Bictegravir include Gilead Sciences, Cipla, Laurus Labs, Hetero Drugs Limited, Selleck Chemicals, Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical, Changzhou Pharmaceutical Factory, Shanghai Topscience and Jiangsu Coben Pharmaceutical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Bictegravir, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Bictegravir by region & country, by Type, and by Application.

The Bictegravir market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bictegravir.

Market Segmentation

Report Metric
Details
Report Title
Bictegravir - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Bictegravir Companies Covered
Gilead Sciences, Cipla, Laurus Labs, Hetero Drugs Limited, Selleck Chemicals, Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical, Changzhou Pharmaceutical Factory, Shanghai Topscience, Jiangsu Coben Pharmaceutical, ShenZhen HwaGen Pharmaceutical, Shanghai Haoyuan Chemexpress, Shanghai Systeam Biochem
Global Bictegravir Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bictegravir Market, Segment by Type
97% - 99%

Above 99%
Global Bictegravir Market, Segment by Application
Hospitals

Clinics

Labs
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Bictegravir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Bictegravir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Bictegravir in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Bictegravir Product Introduction
    1.2 Global Bictegravir Market Size Forecast
        1.2.1 Global Bictegravir Sales Value (2019-2030)
        1.2.2 Global Bictegravir Sales Volume (2019-2030)
        1.2.3 Global Bictegravir Sales Price (2019-2030)
    1.3 Bictegravir Market Trends & Drivers
        1.3.1 Bictegravir Industry Trends
        1.3.2 Bictegravir Market Drivers & Opportunity
        1.3.3 Bictegravir Market Challenges
        1.3.4 Bictegravir Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Bictegravir Players Revenue Ranking (2023)
    2.2 Global Bictegravir Revenue by Company (2019-2024)
    2.3 Global Bictegravir Players Sales Volume Ranking (2023)
    2.4 Global Bictegravir Sales Volume by Company Players (2019-2024)
    2.5 Global Bictegravir Average Price by Company (2019-2024)
    2.6 Key Manufacturers Bictegravir Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Bictegravir Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Bictegravir
    2.9 Bictegravir Market Competitive Analysis
        2.9.1 Bictegravir Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Bictegravir Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bictegravir as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 97% - 99%
        3.1.2 Above 99%
    3.2 Global Bictegravir Sales Value by Type
        3.2.1 Global Bictegravir Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Bictegravir Sales Value, by Type (2019-2030)
        3.2.3 Global Bictegravir Sales Value, by Type (%) (2019-2030)
    3.3 Global Bictegravir Sales Volume by Type
        3.3.1 Global Bictegravir Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Bictegravir Sales Volume, by Type (2019-2030)
        3.3.3 Global Bictegravir Sales Volume, by Type (%) (2019-2030)
    3.4 Global Bictegravir Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Clinics
        4.1.3 Labs
    4.2 Global Bictegravir Sales Value by Application
        4.2.1 Global Bictegravir Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Bictegravir Sales Value, by Application (2019-2030)
        4.2.3 Global Bictegravir Sales Value, by Application (%) (2019-2030)
    4.3 Global Bictegravir Sales Volume by Application
        4.3.1 Global Bictegravir Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Bictegravir Sales Volume, by Application (2019-2030)
        4.3.3 Global Bictegravir Sales Volume, by Application (%) (2019-2030)
    4.4 Global Bictegravir Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Bictegravir Sales Value by Region
        5.1.1 Global Bictegravir Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Bictegravir Sales Value by Region (2019-2024)
        5.1.3 Global Bictegravir Sales Value by Region (2025-2030)
        5.1.4 Global Bictegravir Sales Value by Region (%), (2019-2030)
    5.2 Global Bictegravir Sales Volume by Region
        5.2.1 Global Bictegravir Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Bictegravir Sales Volume by Region (2019-2024)
        5.2.3 Global Bictegravir Sales Volume by Region (2025-2030)
        5.2.4 Global Bictegravir Sales Volume by Region (%), (2019-2030)
    5.3 Global Bictegravir Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Bictegravir Sales Value, 2019-2030
        5.4.2 North America Bictegravir Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Bictegravir Sales Value, 2019-2030
        5.5.2 Europe Bictegravir Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Bictegravir Sales Value, 2019-2030
        5.6.2 Asia Pacific Bictegravir Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Bictegravir Sales Value, 2019-2030
        5.7.2 South America Bictegravir Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Bictegravir Sales Value, 2019-2030
        5.8.2 Middle East & Africa Bictegravir Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Bictegravir Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Bictegravir Sales Value
        6.2.1 Key Countries/Regions Bictegravir Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Bictegravir Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Bictegravir Sales Value, 2019-2030
        6.3.2 United States Bictegravir Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Bictegravir Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Bictegravir Sales Value, 2019-2030
        6.4.2 Europe Bictegravir Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Bictegravir Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Bictegravir Sales Value, 2019-2030
        6.5.2 China Bictegravir Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Bictegravir Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Bictegravir Sales Value, 2019-2030
        6.6.2 Japan Bictegravir Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Bictegravir Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Bictegravir Sales Value, 2019-2030
        6.7.2 South Korea Bictegravir Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Bictegravir Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Bictegravir Sales Value, 2019-2030
        6.8.2 Southeast Asia Bictegravir Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Bictegravir Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Bictegravir Sales Value, 2019-2030
        6.9.2 India Bictegravir Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Bictegravir Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Gilead Sciences
        7.1.1 Gilead Sciences Company Information
        7.1.2 Gilead Sciences Introduction and Business Overview
        7.1.3 Gilead Sciences Bictegravir Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Gilead Sciences Bictegravir Product Offerings
        7.1.5 Gilead Sciences Recent Development
    7.2 Cipla
        7.2.1 Cipla Company Information
        7.2.2 Cipla Introduction and Business Overview
        7.2.3 Cipla Bictegravir Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Cipla Bictegravir Product Offerings
        7.2.5 Cipla Recent Development
    7.3 Laurus Labs
        7.3.1 Laurus Labs Company Information
        7.3.2 Laurus Labs Introduction and Business Overview
        7.3.3 Laurus Labs Bictegravir Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Laurus Labs Bictegravir Product Offerings
        7.3.5 Laurus Labs Recent Development
    7.4 Hetero Drugs Limited
        7.4.1 Hetero Drugs Limited Company Information
        7.4.2 Hetero Drugs Limited Introduction and Business Overview
        7.4.3 Hetero Drugs Limited Bictegravir Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Hetero Drugs Limited Bictegravir Product Offerings
        7.4.5 Hetero Drugs Limited Recent Development
    7.5 Selleck Chemicals
        7.5.1 Selleck Chemicals Company Information
        7.5.2 Selleck Chemicals Introduction and Business Overview
        7.5.3 Selleck Chemicals Bictegravir Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Selleck Chemicals Bictegravir Product Offerings
        7.5.5 Selleck Chemicals Recent Development
    7.6 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical
        7.6.1 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Company Information
        7.6.2 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Introduction and Business Overview
        7.6.3 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Bictegravir Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Bictegravir Product Offerings
        7.6.5 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Recent Development
    7.7 Changzhou Pharmaceutical Factory
        7.7.1 Changzhou Pharmaceutical Factory Company Information
        7.7.2 Changzhou Pharmaceutical Factory Introduction and Business Overview
        7.7.3 Changzhou Pharmaceutical Factory Bictegravir Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Changzhou Pharmaceutical Factory Bictegravir Product Offerings
        7.7.5 Changzhou Pharmaceutical Factory Recent Development
    7.8 Shanghai Topscience
        7.8.1 Shanghai Topscience Company Information
        7.8.2 Shanghai Topscience Introduction and Business Overview
        7.8.3 Shanghai Topscience Bictegravir Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Shanghai Topscience Bictegravir Product Offerings
        7.8.5 Shanghai Topscience Recent Development
    7.9 Jiangsu Coben Pharmaceutical
        7.9.1 Jiangsu Coben Pharmaceutical Company Information
        7.9.2 Jiangsu Coben Pharmaceutical Introduction and Business Overview
        7.9.3 Jiangsu Coben Pharmaceutical Bictegravir Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Jiangsu Coben Pharmaceutical Bictegravir Product Offerings
        7.9.5 Jiangsu Coben Pharmaceutical Recent Development
    7.10 ShenZhen HwaGen Pharmaceutical
        7.10.1 ShenZhen HwaGen Pharmaceutical Company Information
        7.10.2 ShenZhen HwaGen Pharmaceutical Introduction and Business Overview
        7.10.3 ShenZhen HwaGen Pharmaceutical Bictegravir Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 ShenZhen HwaGen Pharmaceutical Bictegravir Product Offerings
        7.10.5 ShenZhen HwaGen Pharmaceutical Recent Development
    7.11 Shanghai Haoyuan Chemexpress
        7.11.1 Shanghai Haoyuan Chemexpress Company Information
        7.11.2 Shanghai Haoyuan Chemexpress Introduction and Business Overview
        7.11.3 Shanghai Haoyuan Chemexpress Bictegravir Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 Shanghai Haoyuan Chemexpress Bictegravir Product Offerings
        7.11.5 Shanghai Haoyuan Chemexpress Recent Development
    7.12 Shanghai Systeam Biochem
        7.12.1 Shanghai Systeam Biochem Company Information
        7.12.2 Shanghai Systeam Biochem Introduction and Business Overview
        7.12.3 Shanghai Systeam Biochem Bictegravir Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Shanghai Systeam Biochem Bictegravir Product Offerings
        7.12.5 Shanghai Systeam Biochem Recent Development

 8 Industry Chain Analysis
    8.1 Bictegravir Industrial Chain
    8.2 Bictegravir Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Bictegravir Sales Model
        8.5.2 Sales Channel
        8.5.3 Bictegravir Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Bictegravir Market Trends
    Table 2. Bictegravir Market Drivers & Opportunity
    Table 3. Bictegravir Market Challenges
    Table 4. Bictegravir Market Restraints
    Table 5. Global Bictegravir Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Bictegravir Revenue Market Share by Company (2019-2024)
    Table 7. Global Bictegravir Sales Volume by Company (2019-2024) & (Tons)
    Table 8. Global Bictegravir Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Bictegravir Price by Company (2019-2024) & (K US$/Ton)
    Table 10. Key Manufacturers Bictegravir Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Bictegravir Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Bictegravir
    Table 13. Global Bictegravir Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bictegravir as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Bictegravir Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Bictegravir Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Bictegravir Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Bictegravir Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Bictegravir Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Bictegravir Sales Volume by Type: 2019 VS 2023 VS 2030 (Tons)
    Table 22. Global Bictegravir Sales Volume by Type (2019-2024) & (Tons)
    Table 23. Global Bictegravir Sales Volume by Type (2025-2030) & (Tons)
    Table 24. Global Bictegravir Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Bictegravir Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Bictegravir Price by Type (2019-2024) & (K US$/Ton)
    Table 27. Global Bictegravir Price by Type (2025-2030) & (K US$/Ton)
    Table 28. Global Bictegravir Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Bictegravir Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Bictegravir Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Bictegravir Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Bictegravir Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Bictegravir Sales Volume by Application: 2019 VS 2023 VS 2030 (Tons)
    Table 34. Global Bictegravir Sales Volume by Application (2019-2024) & (Tons)
    Table 35. Global Bictegravir Sales Volume by Application (2025-2030) & (Tons)
    Table 36. Global Bictegravir Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Bictegravir Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Bictegravir Price by Application (2019-2024) & (K US$/Ton)
    Table 39. Global Bictegravir Price by Application (2025-2030) & (K US$/Ton)
    Table 40. Global Bictegravir Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Bictegravir Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Bictegravir Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Bictegravir Sales Value by Region (2019-2024) & (%)
    Table 44. Global Bictegravir Sales Value by Region (2025-2030) & (%)
    Table 45. Global Bictegravir Sales Volume by Region (Tons): 2019 VS 2023 VS 2030
    Table 46. Global Bictegravir Sales Volume by Region (2019-2024) & (Tons)
    Table 47. Global Bictegravir Sales Volume by Region (2025-2030) & (Tons)
    Table 48. Global Bictegravir Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Bictegravir Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Bictegravir Average Price by Region (2019-2024) & (K US$/Ton)
    Table 51. Global Bictegravir Average Price by Region (2025-2030) & (K US$/Ton)
    Table 52. Key Countries/Regions Bictegravir Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Bictegravir Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Bictegravir Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Bictegravir Sales Volume, (2019-2024) & (Tons)
    Table 56. Key Countries/Regions Bictegravir Sales Volume, (2025-2030) & (Tons)
    Table 57. Gilead Sciences Company Information
    Table 58. Gilead Sciences Introduction and Business Overview
    Table 59. Gilead Sciences Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2019-2024)
    Table 60. Gilead Sciences Bictegravir Product Offerings
    Table 61. Gilead Sciences Recent Development
    Table 62. Cipla Company Information
    Table 63. Cipla Introduction and Business Overview
    Table 64. Cipla Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2019-2024)
    Table 65. Cipla Bictegravir Product Offerings
    Table 66. Cipla Recent Development
    Table 67. Laurus Labs Company Information
    Table 68. Laurus Labs Introduction and Business Overview
    Table 69. Laurus Labs Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2019-2024)
    Table 70. Laurus Labs Bictegravir Product Offerings
    Table 71. Laurus Labs Recent Development
    Table 72. Hetero Drugs Limited Company Information
    Table 73. Hetero Drugs Limited Introduction and Business Overview
    Table 74. Hetero Drugs Limited Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2019-2024)
    Table 75. Hetero Drugs Limited Bictegravir Product Offerings
    Table 76. Hetero Drugs Limited Recent Development
    Table 77. Selleck Chemicals Company Information
    Table 78. Selleck Chemicals Introduction and Business Overview
    Table 79. Selleck Chemicals Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2019-2024)
    Table 80. Selleck Chemicals Bictegravir Product Offerings
    Table 81. Selleck Chemicals Recent Development
    Table 82. Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Company Information
    Table 83. Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Introduction and Business Overview
    Table 84. Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2019-2024)
    Table 85. Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Bictegravir Product Offerings
    Table 86. Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Recent Development
    Table 87. Changzhou Pharmaceutical Factory Company Information
    Table 88. Changzhou Pharmaceutical Factory Introduction and Business Overview
    Table 89. Changzhou Pharmaceutical Factory Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2019-2024)
    Table 90. Changzhou Pharmaceutical Factory Bictegravir Product Offerings
    Table 91. Changzhou Pharmaceutical Factory Recent Development
    Table 92. Shanghai Topscience Company Information
    Table 93. Shanghai Topscience Introduction and Business Overview
    Table 94. Shanghai Topscience Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2019-2024)
    Table 95. Shanghai Topscience Bictegravir Product Offerings
    Table 96. Shanghai Topscience Recent Development
    Table 97. Jiangsu Coben Pharmaceutical Company Information
    Table 98. Jiangsu Coben Pharmaceutical Introduction and Business Overview
    Table 99. Jiangsu Coben Pharmaceutical Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2019-2024)
    Table 100. Jiangsu Coben Pharmaceutical Bictegravir Product Offerings
    Table 101. Jiangsu Coben Pharmaceutical Recent Development
    Table 102. ShenZhen HwaGen Pharmaceutical Company Information
    Table 103. ShenZhen HwaGen Pharmaceutical Introduction and Business Overview
    Table 104. ShenZhen HwaGen Pharmaceutical Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2019-2024)
    Table 105. ShenZhen HwaGen Pharmaceutical Bictegravir Product Offerings
    Table 106. ShenZhen HwaGen Pharmaceutical Recent Development
    Table 107. Shanghai Haoyuan Chemexpress Company Information
    Table 108. Shanghai Haoyuan Chemexpress Introduction and Business Overview
    Table 109. Shanghai Haoyuan Chemexpress Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2019-2024)
    Table 110. Shanghai Haoyuan Chemexpress Bictegravir Product Offerings
    Table 111. Shanghai Haoyuan Chemexpress Recent Development
    Table 112. Shanghai Systeam Biochem Company Information
    Table 113. Shanghai Systeam Biochem Introduction and Business Overview
    Table 114. Shanghai Systeam Biochem Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2019-2024)
    Table 115. Shanghai Systeam Biochem Bictegravir Product Offerings
    Table 116. Shanghai Systeam Biochem Recent Development
    Table 117. Key Raw Materials Lists
    Table 118. Raw Materials Key Suppliers Lists
    Table 119. Bictegravir Downstream Customers
    Table 120. Bictegravir Distributors List
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Bictegravir Product Picture
    Figure 2. Global Bictegravir Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Bictegravir Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Bictegravir Sales Volume (2019-2030) & (Tons)
    Figure 5. Global Bictegravir Sales Price (2019-2030) & (K US$/Ton)
    Figure 6. Bictegravir Report Years Considered
    Figure 7. Global Bictegravir Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Bictegravir Players Sales Volume Ranking (2023) & (Tons)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Bictegravir Revenue in 2023
    Figure 10. Bictegravir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. 97% - 99% Picture
    Figure 12. Above 99% Picture
    Figure 13. Global Bictegravir Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Bictegravir Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Bictegravir Sales Volume by Type (2019 VS 2023 VS 2030) & (Tons)
    Figure 16. Global Bictegravir Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Bictegravir Price by Type (2019-2030) & (K US$/Ton)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Clinics
    Figure 20. Product Picture of Labs
    Figure 21. Global Bictegravir Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Bictegravir Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Bictegravir Sales Volume by Application (2019 VS 2023 VS 2030) & (Tons)
    Figure 24. Global Bictegravir Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Bictegravir Price by Application (2019-2030) & (K US$/Ton)
    Figure 26. North America Bictegravir Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Bictegravir Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Bictegravir Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Bictegravir Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Bictegravir Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Bictegravir Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Bictegravir Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Bictegravir Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Bictegravir Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Bictegravir Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Bictegravir Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Bictegravir Sales Volume (%), (2019-2030)
    Figure 38. United States Bictegravir Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Bictegravir Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Bictegravir Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Bictegravir Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Bictegravir Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Bictegravir Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Bictegravir Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Bictegravir Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Bictegravir Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Bictegravir Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Bictegravir Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Bictegravir Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Bictegravir Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Bictegravir Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Bictegravir Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Bictegravir Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Bictegravir Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Bictegravir Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Bictegravir Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Bictegravir Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Bictegravir Sales Value by Application (%), 2023 VS 2030
    Figure 59. Bictegravir Industrial Chain
    Figure 60. Bictegravir Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed

Description

Bictegravir is a potent HIV-1 integrase inhibitor primarily used to treat type 1 AIDS without a history of antiretroviral therapy.

(HIV-1) adult patients, it can also be used as an alternative drug for patients with no history of treatment failure and drug resistance and HIV-1 RNA less than 50copies/ml.

The global market for Bictegravir was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Bictegravir was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Bictegravir was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Bictegravir was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Bictegravir include Gilead Sciences, Cipla, Laurus Labs, Hetero Drugs Limited, Selleck Chemicals, Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical, Changzhou Pharmaceutical Factory, Shanghai Topscience and Jiangsu Coben Pharmaceutical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Bictegravir, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Bictegravir by region & country, by Type, and by Application.

The Bictegravir market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bictegravir.

Market Segmentation